Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel diamine monomer patent CN105503775A enables stable electrochromic polyamides. Enhances solubility and supply chain reliability for advanced electronic chemical manufacturing.
Patent CN105348250A reveals novel lipid-lowering compound synthesis. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN115160146B reveals a high-yield one-pot synthesis for 1,2-cyclohexanediamine from cyclohexene oxide, offering significant cost reduction and supply chain stability for global buyers.
Patent CN106946714A details a green CeO2-CuO-ZnO-Al2O3 catalyst for DETDA synthesis ensuring high purity and supply chain reliability for global buyers.
Patent CN108484412A details transparent polyimide precursors. Offers supply chain stability and cost efficiency for electronic chemical manufacturing processes globally.
Patent CN111482178A details a continuous fixed-bed process for chloroquine intermediates using supported nano-nickel, offering high purity and reduced environmental impact for reliable supply chains.
Patent CN105503613B reveals advanced Cu Ni catalyst for polyamine production offering reduced corrosion and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN102993024B reveals a safer sulfonation-methylation route for N,N'-dimethyl cyclohexanediamine, offering high purity >98% and significant cost reduction in fine chemical manufacturing.
Patent CN102731316B reveals a safer sulfonyl protection route for 1,2-N,N'-dimethylcyclohexanediamine, offering high purity and industrial scalability for pharmaceutical supply chains.
Novel patent CN104557561B offers safe high-yield route for pramiracetam intermediate ensuring cost reduction and supply stability for global buyers.
Patent CN116789555B enables continuous production of high-purity intermediates. This process offers substantial supply chain reliability and cost reduction advantages.
Patent CN1296472A reveals a method suppressing by-products for high-yield diamine synthesis, offering cost-effective supply chain solutions.
Novel patent CN116102465B details high-yield diamine synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel patent CN116102465B enables high-purity diamine production. Eliminates palladium catalysts and toxic solvents for significant cost reduction and supply chain reliability.
Patent CN106631840B discloses novel diamine monomer enabling high-performance polyimides with electrochromic functions and improved solubility for display materials.
Patent CN101723988A details a novel route for high-purity oxaliplatin with minimal silver and oxalic acid residues, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Novel separation method for trans-1-2-cyclohexanediamine via patent CN117417259A. Enhances purity and supply chain efficiency for pharmaceutical intermediate manufacturing.
Patent CN103755645A details a high-yield, two-step aqueous synthesis for hair growth intermediates, offering significant cost and supply chain advantages.
Patent CN108176392B reveals a composite catalyst for MDA production, eliminating caustic neutralization. Offers significant cost reduction and purity improvements for polyurethane precursors.
Novel synthesis of triazine hydroxyethyl ethylenediamine polycarboxylic acid using cyanuric chloride. Cost-effective rust inhibitor for industrial applications with superior stability.